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Summary and Implications 
 The objective of this study was to evaluate the impact 
of environmental factors on the serological response to 
commercial bovine viral diarrhea type 2 (BVDV2) 
vaccinations in Angus cattle for inclusion as fixed effects 
into subsequent genetic evaluations for response to 
vaccination. 
 Age of calf was found to have a significant effect on the 
serum titer level at the time of initial vaccination, with older 
calves halving a lower titer level.  Furthermore, it was 
observed that animals with a higher serum titer level at the 
time of vaccination had a reduced increase in titer as a result 
of a vaccination.  We also observed smaller response to 
vaccination in calves which experienced the stress of 
weaning at the same time as their initial vaccinations. 
 Based on this initial study, we have adjusted 
experimental protocols for subsequent work to collect 
samples to evaluate individual animal rate of maternal 
antibody decline and to remove confounding of stress of 
weaning with calving season effects. 
 
Introduction 
 Bovine respiratory disease is a very significant disease 
effecting feedlot cattle across the US.  Many 
preconditioning programs include vaccinations for 
(BVDV2) in their protocols to help reduce the incidence of 
bovine respiratory disease in the feedlot.  We are interested 
in evaluating the genetic control of response to respiratory 
disease vaccines as a potential new economically relevant 
trait for beef cattle selection in the future. 
 When beginning to investigate genetic control of a new 
trait, it is also important to characterize non-genetic effects 
on that trait.  An example of this concept can be adapted 
from weaning weight EPD calculations.  Weaning records 
are typically adjusted to a constant age before calculation of 
EPDs for weaning weight because it is well documented that 
cattle get heavier as they get older.  Therefore, the objective 
of this study was to evaluate the impact of environmental 
factors on the serological response to vaccination for a 
commercial BVDV2 vaccine. 
 
Materials and Methods 
 This study utilized 353 Angus calves born in spring (n 
= 176) and fall (n = 177) calving seasons of 2006 in the 
Iowa State University Angus Breeding Project.  Two 
vaccinations, initial and booster, were administered approx. 
3 weeks apart.  Blood serum samples were collected at time 
of initial vaccination, booster vaccination, and approx. 2 
weeks after booster vaccination for response to booster.  
Spring calves were weaned and given initial vaccination at 
the same time, while fall calves were weaned at the time of 
booster vaccination administration (Figure 1). 
 The level of neutralizing antibodies present in sera was 
titered via serum neutralization tests using cytopathic 
BVDV2.  Briefly, each serum was serially diluted 1:2 and 
the highest dilution of serum which was still capable of 
neutralizing virus was determined.  All tests were run in 
triplicate.  The reciprocal of the average of the highest 
dilution, which had virus neutralizing activity, was recorded 
as the serum titer.   
 Response to initial vaccination was calculated as serum 
titer at time of booster vaccination minus serum titer at time 
of initial vaccination.  Response to booster vaccination was 
calculated as serum titer at time of booster response serum 
draw minus serum titer at time of booster vaccination.  
Overall response to initial and booster vaccination was 
calculated as serum titer level at time of booster response 
serum draw minus serum titer level at time of initial 
vaccination. 
 
Results and Discussion 
 Means, standard deviations, and ranges for ages and 
titer levels at initial vaccination, booster vaccination, and 
response to booster vaccination serum draw are presented in 
Table 1 by calving group. 
 Titer levels at the time of first vaccination were not 
influenced by gender (P = 0.13) but were influenced by 
calving group (spring or fall) (P < 0.001) and calf age (P < 
0.001) (Figure 2).  This observation may result from a 
higher level of maternal antibodies in younger calves.  There 
was no interaction between group and age of calf covariate 
(P = 0.89) for titer level at the time of first vaccination, 
indicating maternal antibodies have a similar half-life in 
both calving groups. 
 When evaluating the response to the different 
vaccinations (initial, booster, and overall initial and booster) 
we evaluated the significance of class effects of calving 
season and gender of calf as well as covariates for serum 
titer level at the time of vaccination, age at the time of 
vaccination, and weight at the time of vaccination.  
Significance level for these effects and estimates of the 
covariate effects are presented in Table 2. 
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 Titer level at the time vaccination was consistently the 
most significant effect (P < 0.001 for all three response 
variables) for predicting response to vaccination strategy, 
with animals having a higher initial titer level experiencing 
a smaller increase in titer as a result of a vaccination 
strategy.  Other effects tested for significance for prediction 
of response to vaccination included calving group, gender, 
age at vaccination, and weight at vaccination.  Calving 
group was the next most significant effect for predicting 
response to initial vaccination and overall vaccination (P < 
0.001 and P < 0.05, respectively).  LSMeans estimates for 
the response to initial vaccination were -1.49 and 0.31 for 
the spring calving and fall calving groups respectively.  
Furthermore, LSMeans estimates for the response to overall 
vaccination program were 1.52 and 2.21 for spring calving 
and fall calving groups respectively.  Therefore, it appears 
that stress of weaning at the same time as initial vaccination 
may limit the ability of animals to respond to a vaccine. 
 Unfortunately, the design of this study had confounding 
of some important effects.  The first effect confounded 
between calving groups was the weaning strategy, with 
spring born calves all experiencing the stress of weaning at 
the time of initial vaccination and the fall born calves all 
experiencing the stress of weaning at the time of booster 
vaccination.  Also, there was a general confounding of age 
of calf with these two calving groups.  Generally, the spring 
calving group was older at the time of initial vaccination and 
was also generally older at the time of weaning.  This lead 
to a number of animals in the spring calving group being old 
enough to have 0.00 serum titer level at the time of initial 
vaccination, whereas, the fall calving group did not have 
any animals with 0.00 serum titer level at the time of initial 
vaccination, thus potentially limiting the response to the 
initial vaccination in the fall born group. 
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Figure 1. Design layout with distribution of ages of 2006 spring or fall born calf management groups and timing of 
weaning during response to BVDV2 vaccination study. 
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Figure 2. Relationship between age of calf and initial titer level before exposure to BVDV2 vaccine. 
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Table 1. Means, standard deviations, and ranges for ages and titer levels at initial vaccination, booster vaccination, 
and response to booster vaccination serum draw. 
 n Mean SD Min Max 
Spring born group      
    Initial Vacc. Age, d 176 170 15.4 123 194 
    Initial Vacc. Wt, lb 176 400 62.2 245 555 
    Initial Vacc. Titer, 2X dilutions 176 2.23 1.80 0.00 7.50 
    Booster Vacc. Age, d 176 189 15.4 142 213 
    Booster Vacc. Wt, lb 176 438 70.5 260 600 
    Booster Vacc. Titer, 2X dilutions 176 1.42 1.61 0.00 6.50 
    Titer response to Initial Vacc. (Booster – 
Initial), 2X dilutions 
176 -0.81 1.62 -5.25 4.50 
    Resp. to Booster Vacc. Age, d 176 203 15.4 156 227 
    Resp. to Booster Vacc. Wt, lb 176 445 74.9 255 635 
    Resp. to Booster Vacc. Titer, 2X dilutions 176 5.38 1.75 0.00 9.50 
    Titer response to Booster Vacc. (Resp. to 
Booster – Booster), 2X dilutions 
176 3.96 2.09 -1.75 9.00 
    Titer response to Overall Vacc. (Resp. to 
Booster – Initial), 2X dilutions 
176 3.14 2.68 -3.50 9.50 
      
Fall born group      
    Initial Vacc. Age, d 177 127 13.9 92 149 
    Initial Vacc. Wt, lb 177 311 47.7 175 445 
    Initial Vacc. Titer, 2X dilutions 177 5.20 1.32 1.75 8.50 
    Booster Vacc. Age, d 177 148 13.9 113 170 
    Booster Vacc. Wt, lb 177 353 52.4 215 485 
    Booster Vacc. Titer, 2X dilutions 177 4.82 1.33 0.00 7.75 
    Titer response to Initial Vacc. (Booster – 
Initial), 2X dilutions 
177 -0.38 1.03 -2.75 2.89 
    Resp. to Booster Vacc. Age, d 177 162 13.9 127 184 
    Resp. to Booster Vacc. Wt, lb 177 402 61.0 250 545 
    Resp. to Booster Vacc. Titer, 2X dilutions 177 5.80 1.11 3.00 8.50 
    Titer response to Booster Vacc. (Resp. to 
Booster – Booster), 2X dilutions 
177 0.98 1.62 -3.39 5.50 
    Titer response to Overall Vacc. (Resp. to 
Booster – Initial), 2X dilutions 
177 0.59 1.82 -3.25 5.5 
      
 
 
Table 2. Significance and estimates of effects for predicting response to vaccination for initial, booster, or overall 
vaccination strategy. 
 
Response to 
initial 
vaccination,  
P-Value 
Response to 
initial 
vaccination, 
Estimate 
Response to 
booster 
vaccination, 
P-Value 
Response to 
booster 
vaccination, 
Estimate 
Overall 
response to 
initial and 
booster 
vaccination,  
P-Value 
Overall 
response to 
initial and 
booster 
vaccination, 
Estimate 
Full Model, R2  0.295  0.646  0.694 
    Calving group <0.001  0.75  <0.05  
    Titer at vaccination,  
        2X dilutions 
<0.001 -0.424 <0.001 -0.786 <0.001 -1.109 
    Gender <0.01  0.31  0.68  
    Age at vaccination, d <0.10 0.0093 <0.10 0.0112 0.57 0.0039 
    Weight at vaccination, lb <0.05 -0.0033 <0.10 -0.0029 0.16 -0.0025 
       
 
